As expected, CD11c+ DCs including CD103+, CD8α+ and CD11b+ DCs were significantly expanded in blood of tumor-bearing mice after repeated subcutaneous injections of Flt3L (Additional file 1: Figure S6a-c), confirming the effectiveness of Flt3L. Here, ITGAX is linked to neoplasm.